Literature DB >> 12946876

11beta-hydroxysteroid dehydrogenase: unexpected connections.

Elizabeth A Walker1, Paul M Stewart.   

Abstract

Mesh：

Substances：

Year:  2003        PMID： 12946876     DOI： 10.1016/s1043-2760(03)00134-6

Source DB:  PubMed          Journal:  Trends Endocrinol Metab        ISSN： 1043-2760            Impact factor:   12.015


× No keyword cloud information.
  8 in total

Review 1.  The molecular biology, biochemistry, and physiology of human steroidogenesis and its disorders.

Authors:  Walter L Miller; Richard J Auchus
Journal:  Endocr Rev       Date:  2010-11-04       Impact factor: 19.871

2.  Time lag between peak concentrations of plasma and salivary cortisol following a stressful procedure in dairy cattle.

Authors:  Carlos E Hernandez; Tomas Thierfelder; Kerstin Svennersten-Sjaunja; Charlotte Berg; Agustin Orihuela; Lena Lidfors
Journal:  Acta Vet Scand       Date:  2014-10-09       Impact factor: 1.695

3.  Hepatic Glucocorticoid Receptor Plays a Greater Role Than Adipose GR in Metabolic Syndrome Despite Renal Compensation.

Authors:  Sandip K Bose; Irina Hutson; Charles A Harris
Journal:  Endocrinology       Date:  2016-10-18       Impact factor: 4.736

4.  Overexpression of 11beta-hydroxysteroid dehydrogenase type 1 in hepatic and visceral adipose tissue is associated with metabolic disorders in morbidly obese patients.

Authors:  René Baudrand; Cristian A Carvajal; Arnoldo Riquelme; Mauricio Morales; Nancy Solis; Margarita Pizarro; Alex Escalona; Camilo Boza; Gustavo Pérez; Angélica Domínguez; Marco Arrese; Carlos E Fardella
Journal:  Obes Surg       Date:  2009-08-19       Impact factor: 4.129

5.  Evidence of altered cortisol metabolism in critically ill patients: a prospective study.

Authors:  Bala Venkatesh; Jeremy Cohen; Ingrid Hickman; Janelle Nisbet; Peter Thomas; Gregory Ward; Jonathan Hall; John Prins
Journal:  Intensive Care Med       Date:  2007-06-09       Impact factor: 17.440

6.  The role of glucocorticoid action in the pathophysiology of the Metabolic Syndrome.

Authors:  Minghan Wang
Journal:  Nutr Metab (Lond)       Date:  2005-02-02       Impact factor: 4.169

Review 7.  Androgen Receptor: A Complex Therapeutic Target for Breast Cancer.

Authors:  Ramesh Narayanan; James T Dalton
Journal:  Cancers (Basel)       Date:  2016-12-02       Impact factor: 6.639

8.  Oral administration of the 11β-hydroxysteroid-dehydrogenase type 1 inhibitor RO5093151 to patients with glaucoma: an adaptive, randomised, placebo-controlled clinical study.

Authors:  Dietmar Schwab; Carolina Sturm; Agnès Portron; Sabine Fuerst-Recktenwald; Dominik Hainzl; Paul Jordan; William C Stewart; Michael E Tepedino; Harvey DuBiner
Journal:  BMJ Open Ophthalmol       Date:  2017-06-29
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.